Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|November 23, 2020
Genetic risk factors in the development of idiosyncratic drug-induced liver injuryCamilla Stephens, M Isabel Lucena, Raúl J Andrade
Journal of Hepatology|December 19, 2024
Reply to: Correspondence on 'Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network'Antonio Segovia-Zafra, M Isabel Lucena, Raul J Andrade
Journal of Hepatology|March 30, 2024
Reply to: "Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface"Einar S Björnsson, M Isabel Lucena, Raul J Andrade
The American Journal of Gastroenterology|August 16, 2022
RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI DiagnosisPaul H Hayashi, M Isabel Lucena, Robert J Fontana
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Methods for causality assessment of idiosyncratic drug-induced liver injuryMiren García-Cortés, Gonzalo Matilla-Cabello, M Isabel Lucena
World Journal of Hepatology|May 7, 2014
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported diseaseAgustin Castiella, Eva Zapata, M Isabel Lucena, et al.
Expert Opinion on Drug Safety|August 9, 2003
Antidepressant-induced hepatotoxicityM Isabel Lucena, Alfonso Carvajal, Raúl J Andrade, et al.
Croatian Medical Journal|December 17, 2010
Reflections on running training workshops for research ethics committee members in Spain between 2001 and 2008Josep-E Baños, M Isabel Lucena, Elisabet Serés, et al.
Pharmacogenomics|September 19, 2009
Drug-induced liver injury: insights from genetic studiesRaúl J Andrade, Mercedes Robles, Eugenia Ulzurrun, et al.
International Journal of Molecular Sciences|March 4, 2016
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic InitiativeFernando Bessone, Nelia Hernandez, M Isabel Lucena, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Expert Opinion on Drug Metabolism & Toxicology|November 23, 2020
Genetic risk factors in the development of idiosyncratic drug-induced liver injuryCamilla Stephens, M Isabel Lucena, Raúl J Andrade
Journal of Hepatology|December 19, 2024
Reply to: Correspondence on 'Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network'Antonio Segovia-Zafra, M Isabel Lucena, Raul J Andrade
Journal of Hepatology|March 30, 2024
Reply to: "Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface"Einar S Björnsson, M Isabel Lucena, Raul J Andrade
The American Journal of Gastroenterology|August 16, 2022
RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI DiagnosisPaul H Hayashi, M Isabel Lucena, Robert J Fontana
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Methods for causality assessment of idiosyncratic drug-induced liver injuryMiren García-Cortés, Gonzalo Matilla-Cabello, M Isabel Lucena
World Journal of Hepatology|May 7, 2014
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported diseaseAgustin Castiella, Eva Zapata, M Isabel Lucena, et al.
Expert Opinion on Drug Safety|August 9, 2003
Antidepressant-induced hepatotoxicityM Isabel Lucena, Alfonso Carvajal, Raúl J Andrade, et al.
Croatian Medical Journal|December 17, 2010
Reflections on running training workshops for research ethics committee members in Spain between 2001 and 2008Josep-E Baños, M Isabel Lucena, Elisabet Serés, et al.
Pharmacogenomics|September 19, 2009
Drug-induced liver injury: insights from genetic studiesRaúl J Andrade, Mercedes Robles, Eugenia Ulzurrun, et al.
International Journal of Molecular Sciences|March 4, 2016
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic InitiativeFernando Bessone, Nelia Hernandez, M Isabel Lucena, et al.
Pageof 16